[
  {
    "content": "**The Role of Counterarguments**\n\nA key aspect of Sextus\u2019s skepticism is evaluating arguments through the lens of counterarguments.",
    "id": "a0bccb69-7236-4fb1-97d8-ae80a2034133"
  },
  {
    "content": "I've been a big JM Subs fan since our area's first location opened up in Oldsmar years ago.",
    "id": "6cc8b2cb-74e6-4b50-be94-09d6d68679b0"
  },
  {
    "content": "They think about the zoo and feel excited.",
    "id": "12c806f1-0718-49f3-82df-8c0f708e4cf1"
  },
  {
    "content": "I asked the cool dude who works at the Gravois Bluffs in Fenton if I could please try just one piece of the fried corn-on-the-cob, with money being so short these days (I work my 40 hrs as WFH, but bills are creeping up.)",
    "id": "34e44735-e702-405c-b307-d8d734087283"
  },
  {
    "content": "/ 7:30 a.m. P.T.",
    "id": "d03e14de-c4ec-4ae1-a8c0-1136510daf0b"
  },
  {
    "content": "- Train employees on effective feedback techniques, focusing on growth and improvement rather than blame or criticism.",
    "id": "b383d085-7fe8-4ca5-a0e8-b473f00b5663"
  },
  {
    "content": "Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)",
    "id": "e4ba2669-49af-4b37-b6ff-d876c8613229"
  },
  {
    "content": "**Timeline and Budget Reverse Engineering**:\n   - Start with the desired outcomes and work backward to create realistic timelines and budgets.",
    "id": "4f29f0b2-a389-46ae-a484-09d0acb48a4e"
  },
  {
    "content": "The biotech's gene therapy for Duchenne's muscular dystrophy could hit the market sooner than expected.",
    "id": "eb845f3e-85cb-4bbb-ad8e-1602444e7aff"
  },
  {
    "content": "By adopting interdisciplinary approaches, comprehensive research methods, and best practices, individuals and organizations can foster a more nuanced understanding of brain function, leading to improved outcomes in mental health, education, and overall human performance.",
    "id": "a0c2a0ea-5cab-4290-84be-2aed1a20d643"
  },
  {
    "content": "They charged me for 8-items.",
    "id": "9a1628c3-c43a-4ffe-9afd-f5c6d172bea1"
  },
  {
    "content": "They like to play in the park.",
    "id": "66f00be6-c176-47d0-9490-0a1043023480"
  },
  {
    "content": "But they don't register surprise in the sudden appearance of this blond, white skinned girl in peculiar dress.",
    "id": "670e80c0-70bc-4de7-8ab7-d845777c9df1"
  },
  {
    "content": "4.",
    "id": "e93d1902-b097-4d18-8f1b-60578a07d3b9"
  },
  {
    "content": "He was really wonderful.",
    "id": "42c9328f-c332-477b-aef6-97114b50ffa0"
  },
  {
    "content": "They threw them at the trees and bushes.",
    "id": "ca4f96cd-7a5b-4550-9bd9-0ace20eddb42"
  },
  {
    "content": "Next-generation PPMO drugs are being advanced in order to improve upon the first generation types; in addition, other mutations observed in DMD are being targeted as well.",
    "id": "d5543b65-8283-4739-89ff-924626f83c71"
  },
  {
    "content": "Myrtle (Rowland) says she's an actress and that's the only thing she knows how to do; and I imagine that if I had a friend who was a professional performer, it would be really difficult to tell when he's saying the truth because I would know he's an actor and he can fake anything at any time.",
    "id": "168d28e0-8ae3-49f1-bf7a-f1d59e194754"
  },
  {
    "content": "I really look forward to seeing what this filmmaker does next, i could imagine a career along the lines of Woody Allen or Albert Brooks, although usually when a guy like this breaks through, he goes off and makes \" X MEN\" and his humble quirky origins are soon forgotten or are they.... X Men is aout a bunch of freaks if i remember correctly :)",
    "id": "b74d93e6-bb6b-46dd-8a85-c972e9948b26"
  },
  {
    "content": "E.T., the Company will host a conference call to discuss its second quarter 2021 financial results and to provide a corporate update.",
    "id": "dd119fb8-a072-425b-b7b1-8bd8339f29ee"
  },
  {
    "content": "#### III.",
    "id": "9b1916e5-193e-4cfa-8844-c1d3f0b54a9b"
  },
  {
    "content": "What's next for the stock?",
    "id": "3725308f-61dc-4bc5-a2eb-bc8c7a114c65"
  },
  {
    "content": "Very clean and neat.",
    "id": "da8fbebc-a16e-4790-a31c-3e732d58f27b"
  },
  {
    "content": "2.",
    "id": "3d3628a5-a216-48cc-b8b9-136e9a920a67"
  },
  {
    "content": "I settled on a sedan that was also dirty, but not as bad as the van.",
    "id": "44597888-ee7a-4dbb-9315-b212f54dee36"
  },
  {
    "content": "They ran towards the bird with their spears.",
    "id": "f620d890-dcea-4d02-a68a-cbfe7faa124c"
  },
  {
    "content": "Hitchcock could only dream of what DePalma shows in his thrillers.<br /><br />Sadly, the original uncut version of \"Dressed to Kill\" is no longer available on video.",
    "id": "35641802-d7d9-43a2-bf68-a8d17f991752"
  },
  {
    "content": "He is just mean and jealous.",
    "id": "67e4750b-c08e-48e4-915e-badad75f3a3c"
  },
  {
    "content": "\"Okay!\"",
    "id": "f119d112-9c44-40fc-a846-8ddb181aa8d5"
  },
  {
    "content": "Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 67.74% and 11.33%, respectively, for the quarter ended September 2021.",
    "id": "6441e0cf-d95b-4829-b9b6-0231c4a3340d"
  },
  {
    "content": "Sarepta Therapeutics Inc\u00a0(NASDAQ: SRPT) is\u00a0walking away from a three-year licensing pact\u00a0for a rare disease gene therapy candidate, leaving its former partner on its own as it prepares for a pivotal readout in mid-year.",
    "id": "e917de98-623e-43f0-a179-306be2fbc620"
  },
  {
    "content": "\"Yes, Ben, I am.",
    "id": "81e4898f-354a-45df-86ec-5645afb94224"
  },
  {
    "content": "And the storyline was actually not Cinderella but Queen Victoria, maybe u missed that detail.<br /><br />But anyway.... yea the history in this movie is great, I love historical movies and Queen Victoria is very fascinating!",
    "id": "0ab6fd09-8927-42b2-a244-ff7ceb2567ec"
  },
  {
    "content": "Sarepta will update investors Thursday on the data it hopes will persuade U.S. regulators to accelerate approval of its gene therapy treatment for muscular dystrophy.",
    "id": "1d20d9e8-dfca-4332-9767-ddddd439fd32"
  },
  {
    "content": "Do the numbers hold clues to what lies ahead for the stock?",
    "id": "d5011366-dd5c-453d-baa7-6a255961b74b"
  },
  {
    "content": "I generally prefer to come in and order so I can order my drink, pay for it, then run to the loo or use the free wifi while It's being made.",
    "id": "f89e131d-3453-4b07-b4d5-197b23458675"
  },
  {
    "content": "2.",
    "id": "005bcb2d-8882-4199-bf49-af994a93637c"
  },
  {
    "content": "She, in turn, will soon discover her own love for Fanfan.",
    "id": "2ecc475c-67ad-4008-a3f9-8781fc2cb37c"
  },
  {
    "content": "She asked her mom if she could poke her cat instead.",
    "id": "6b55ca2f-916d-4634-ae75-18ace3cc5b38"
  },
  {
    "content": "**Multi-Disciplinary Input**:\n   - Involve various stakeholders in planning to incorporate diverse perspectives and expertise, enhancing the accuracy of timelines and resource estimates.",
    "id": "ca6e5f84-5c06-4ac2-899b-cbe24c9c5a78"
  },
  {
    "content": "CAMBRIDGE, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced positive 12-week expression and safety results from the first 11 participants enrolled in Study SRP-9001-103, an open-label study known as ENDEAVOR being conducted in partnership with Roche.",
    "id": "0d2a3644-9707-460d-9bed-c1a317c9b54e"
  },
  {
    "content": "We have feelings too.",
    "id": "b53f3c2d-4252-41bc-9461-fd83bb0d76ae"
  },
  {
    "content": "I have also heard people whine about this film being shot on video.",
    "id": "157df40e-937a-400a-b12c-b632140db274"
  },
  {
    "content": "But when they lower the boom on him, he shatters very quickly.",
    "id": "cc3670d5-246b-48ad-b3ce-609ffc022d58"
  },
  {
    "content": "The data comes from the first 11 enrolled participants in a study of 20 participants who are between the ages of 4 and 7 years old.",
    "id": "c763df8d-cfb6-469f-9be8-4a0dada8bdbf"
  },
  {
    "content": "Everyone in it is excellent, and it's one of Cassavettes's best films.",
    "id": "ceea080c-5e66-4cf5-8727-98e015e6678a"
  },
  {
    "content": "I like Starbucks.",
    "id": "7366b965-92b6-4c29-845d-563428266d43"
  },
  {
    "content": "So I emailed corporate.",
    "id": "5fd4cf66-2a80-426b-b902-fcd2df869b1c"
  },
  {
    "content": "Enjoy!\"",
    "id": "138549f3-df9f-4f5d-8b4e-7ddb8cb47dda"
  },
  {
    "content": "### Strategic Framework: Practical Implementation of Robust Regression Analysis\n\n1.",
    "id": "d0a2dee3-afba-4333-b79a-5674febaa73f"
  },
  {
    "content": "He grabs the loop and swings on it.",
    "id": "a1360062-d8e9-4489-953b-053217aacbe8"
  },
  {
    "content": "#### 4.",
    "id": "a4b899f7-677e-40dd-be46-c45b278255ca"
  },
  {
    "content": "Clark fights to find the truth about his own personality and origin.<br /><br />\"Labyrinth\" is undoubtedly the most intriguing episode of \"Smallville\".",
    "id": "acb01bdb-a123-4649-a0ac-46d627a24b56"
  },
  {
    "content": "The prostitute is the sole witness of the crime.",
    "id": "256bad8d-7690-4321-8f63-6f5280eb0381"
  },
  {
    "content": "They had to find and collect as many rare stones as they could.",
    "id": "7469743d-74fe-4f9d-833f-c0ba0de293b5"
  },
  {
    "content": "Would be great on a double bill with Mulholland Drive.<br /><br />",
    "id": "d0b2ee29-74ed-40f5-a36f-7260a9d7774f"
  },
  {
    "content": "She kisses Tom's cheek.",
    "id": "013236bc-ba5c-4eb4-986f-e366c17c6b5f"
  },
  {
    "content": "**Operational Efficiency**\n5.",
    "id": "5f348421-5a62-47d1-b71f-7869997d8c61"
  },
  {
    "content": "She hoped her birthday would be better and happier.",
    "id": "f32a6ca0-643e-4b1b-aad0-001b31323610"
  },
  {
    "content": "### Strategic Framework to Implement Radical Transparency with OKRs\n\n#### 1.",
    "id": "86fe0ac5-e7fb-4414-9f93-e1dc3ec126d7"
  },
  {
    "content": "\"No, they are not!",
    "id": "919e8d43-ba7d-4c37-9b8d-aee49c2d845e"
  },
  {
    "content": "Evaluations should consider practical implications alongside theoretical predictions.",
    "id": "242fab60-904d-4d28-b2cc-2121b5cfcd83"
  },
  {
    "content": "Do the numbers hold clues to what lies ahead for the stock?",
    "id": "7552edf5-0e86-47ed-b01f-f8b3d76a631c"
  },
  {
    "content": "You will get hurt!\"",
    "id": "e9676be7-81eb-4df3-9bd9-efff5f576910"
  },
  {
    "content": "from the first minute to the last in 'opening night' i was completely and utterly absorbed.",
    "id": "a53f28b5-71c9-460f-9702-238450d1cfec"
  },
  {
    "content": "- Measure chat trends and social media discussions regarding assets to understand public sentiment.",
    "id": "93f99a8d-af74-4c77-9e8c-b3ac2102d9a0"
  },
  {
    "content": "Anyways*, back to WS, my favorite part of the chicken is the thigh.",
    "id": "c178a932-7cd8-4b7b-af0f-aa0687555b37"
  },
  {
    "content": "Thereafter the story is quite plain from the Gallic gestures and the running, jumping, and swordplay.<br /><br />On the minus side, the obviousness of the story and the heavy-handed facetiousness of the tone become somewhat wearying, and it is annoying that the French apparently consider themselves too superior to Hollywood to bother even attempting the plausibility of its exciting stunts.",
    "id": "994e5dd4-f4df-4c91-81e5-5173ce9b6770"
  },
  {
    "content": "We believe that \u200bSarepta Therapeutics stock, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, is a good buying opportunity at the present time.",
    "id": "deaf0edd-5d90-4b60-bfbb-16c8b0043966"
  },
  {
    "content": "These events are often associated with sudden technological changes, market disruptions, or other unforeseen opportunities that can rapidly propel a business to success.",
    "id": "452d6045-97fd-49ef-8eb4-18d7f6a4765a"
  },
  {
    "content": "Organizations must recognize the importance of these unpredictable occurrences and proactively prepare for their potential impacts.",
    "id": "49978b0e-0db9-4594-8430-c952e0f9e68c"
  },
  {
    "content": "he shouts.",
    "id": "0282d2d8-3c5e-4029-a23f-641a90cc1c67"
  },
  {
    "content": "Mom turned off the light and left the room.",
    "id": "57626671-df04-4ee4-978c-8ca683107ddf"
  },
  {
    "content": "**Subjectivity of Mental States**: Mental states, such as depression or anxiety, involve a complex interplay between neural activity, personal history, and subjective experiences\u2014not merely a product of brain anatomy.",
    "id": "ef14b44b-5049-4d18-99f1-d58cc45ce563"
  },
  {
    "content": "Today was my second day in a row going to this Subway, and it was great!",
    "id": "a9b88def-a0c1-4c9f-87b2-da64292b2827"
  },
  {
    "content": "The revenue grew 49% Q/Q.",
    "id": "d4c0bf15-9c52-4d93-8412-09ac13fd2373"
  },
  {
    "content": "It made a loud noise.",
    "id": "12fc7fcc-e516-4f07-a2fa-a516dbd61f20"
  },
  {
    "content": "The stock price of Sarepta Therapeutics, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, plunged 12% yesterday, while it is down 14% in the last five trading days.",
    "id": "1f06cf3e-6e39-4281-b0a6-75c98b0ad40a"
  },
  {
    "content": "Service was A+ though.",
    "id": "336d90cb-9bdc-4ff5-995b-2f45ba352ba3"
  },
  {
    "content": "Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 11.11% and 3.59%, respectively, for the quarter ended March 2022.",
    "id": "38f06630-7788-42f1-ac97-ec2c8ca72bc5"
  },
  {
    "content": "Give them back!\"",
    "id": "7448a704-5159-4b51-851d-7db8a83c121b"
  },
  {
    "content": "This movie has the thought occur to him, but too late.",
    "id": "a1644e54-9f0e-4f1c-bb1d-185fe852ec64"
  },
  {
    "content": "You are tired and cold.",
    "id": "aef3952c-299c-4ff3-b117-1912523c2b12"
  },
  {
    "content": "Then, something bad happened.",
    "id": "5f2f2944-2974-4692-b8e9-e44cd6bd6e65"
  },
  {
    "content": "CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2022 at 10:30 a.m. E.T.",
    "id": "dbc17c96-e896-4bd7-92d4-1f1d50ee5cbd"
  },
  {
    "content": "Sarepta's (SRPT) lead gene therapy candidate, SRP-9001, demonstrates robust improvement in expression of micro-dystrophin protein in DMD patients after 12 weeks of treatment.",
    "id": "04140d12-b6f8-499d-a08b-0b12422e1775"
  },
  {
    "content": "- **Reputational Risk**: Damage stemming from unexpected incidents that affect public perception.",
    "id": "36cef023-93e2-42cf-91c7-99254d3531c3"
  },
  {
    "content": "This two-part TV mini-series isn't as good as the original from 1966 but it's solid.",
    "id": "de3ded6c-9b4e-4654-b94f-7cf493647a1b"
  },
  {
    "content": "Who can argue with a Bozo the Clown type who reads adult literature?",
    "id": "eb2775e8-7cd0-445b-8ca6-219c36f0d7df"
  },
  {
    "content": "It still boggles my mind that, after the Clutters were locked in the bathroom, that Herb Clutter didn't force out the window so at least his children would have a chance to escape.",
    "id": "eca990fe-2d4a-40f1-bf03-2f7e83df748d"
  },
  {
    "content": "So we got in and out pretty quick.",
    "id": "ebccf704-ffc6-45bd-b61b-d0dfe2afee01"
  },
  {
    "content": "\"Ha ha!",
    "id": "b1d42f80-1160-4ba6-9abb-f434532723d4"
  },
  {
    "content": "### The Role of Practical Knowledge vs.",
    "id": "1639d761-05b6-433f-987f-4ef82b357a04"
  },
  {
    "content": "Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q4 2021 Results - Earnings Call Transcript",
    "id": "71206581-ab81-4496-8205-76eca5ef065b"
  },
  {
    "content": "I unwrapped my food to find the most perfect subway sandwich I think I've ever seen.",
    "id": "5ed77bdd-e1ca-4579-8472-2838c0909535"
  },
  {
    "content": "She said, \"I'm sorry, robot.",
    "id": "537ea5fc-fe53-49c5-a593-ebef23cff14b"
  },
  {
    "content": "ARK Invest's founder and CEO isn't shy about averaging down on her favorite growth stocks.",
    "id": "48996576-af18-4db3-918f-64032e26e0b7"
  },
  {
    "content": "This film is not without flaws - it is overly long, and the last part of the film where Myrtle goes on stage while very drunk seems almost cruel.",
    "id": "42f51516-3ab7-40be-9f19-d0012fe5e889"
  },
  {
    "content": "It's small but I was greeted upon walking in with a \"welcome to subway\" which was nice.",
    "id": "b04e6bb4-2fa4-410d-84fc-6e37263bbd3d"
  },
  {
    "content": "When I arrived, the app said that my order had already been picked up.",
    "id": "2aff8c88-d73d-4f1e-9a61-83b8d720490b"
  }
]